Coegin Pharma AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-22.83	-23.78	-27.98	-35.24	-27.15	-46.24
Depreciation & Amortization	3.02	3.02	3.02	2.72	0.01	0.02
Other Operating Activities	0.02	0.01	-0.01	-	-	37.14
Change in Accounts Receivable	0.41	-0.5	2.49	1.52	-2.18	2.36
Change in Accounts Payable	-2.39	-2.39	0.44	-	-	-
Change in Other Net Operating Assets	0.01	-	-	-7.24	7.83	-1.06
Operating Cash Flow	-21.77	-23.64	-22.03	-38.23	-21.49	-7.78
Cash Acquisitions	-	-	-	12.01	-	-
Divestitures	-0.05	-0.05	-	-	-	-
Investing Cash Flow	-0.05	-0.05	-	12.01	-	-
Long-Term Debt Issued	-	-	4	4	-	-
Long-Term Debt Repaid	-	-3.5	-4	-	-	-
Net Debt Issued (Repaid)	-	-3.5	-	4	-	-
Issuance of Common Stock	20.37	45.03	26.83	-	31.73	16.93
Other Financing Activities	-1.36	-3.66	-3.08	-	-2.39	6.93
Financing Cash Flow	19.01	37.87	23.75	4	29.35	23.86
Foreign Exchange Rate Adjustments	-0.07	-0.05	-	0.38	1.15	-1.2
Net Cash Flow	-2.88	14.13	1.72	-21.84	9.01	14.88
Levered Free Cash Flow	-13.25	-19.25	-11.45	-19.61	-11.33	-
Unlevered Free Cash Flow	-13.24	-18.96	-11.42	-19.47	-11.33	-
Change in Net Working Capital	1.98	7.4	-2.94	0.51	-5.65	-

Updated Jan 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.